rs554931092

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 4P and 1B. PM1PP3_ModerateBS1_Supporting

The NM_006567.5(FARS2):​c.550G>A​(p.Asp184Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000942 in 1,613,036 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000083 ( 0 hom. )

Consequence

FARS2
NM_006567.5 missense

Scores

9
6
3

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:7

Conservation

PhyloP100: 9.45

Publications

1 publications found
Variant links:
Genes affected
FARS2 (HGNC:21062): (phenylalanyl-tRNA synthetase 2, mitochondrial) This gene encodes a protein that transfers phenylalanine to its cognate tRNA. This protein localizes to the mitochondrion and plays a role in mitochondrial protein translation. Mutations in this gene can cause combined oxidative phosphorylation deficiency 14 (Alpers encephalopathy). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
FARS2 Gene-Disease associations (from GenCC):
  • metabolic disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • combined oxidative phosphorylation defect type 14
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hereditary spastic paraplegia 77
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • Leigh syndrome
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 8 uncertain in NM_006567.5
PP3
MetaRNN computational evidence supports a deleterious effect, 0.868
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000204 (31/152192) while in subpopulation AMR AF = 0.00151 (23/15280). AF 95% confidence interval is 0.00103. There are 0 homozygotes in GnomAd4. There are 17 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006567.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FARS2
NM_006567.5
MANE Select
c.550G>Ap.Asp184Asn
missense
Exon 2 of 7NP_006558.1O95363
FARS2
NM_001318872.2
c.550G>Ap.Asp184Asn
missense
Exon 2 of 7NP_001305801.1O95363
FARS2
NM_001374875.1
c.550G>Ap.Asp184Asn
missense
Exon 2 of 7NP_001361804.1O95363

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FARS2
ENST00000274680.9
TSL:1 MANE Select
c.550G>Ap.Asp184Asn
missense
Exon 2 of 7ENSP00000274680.4O95363
FARS2
ENST00000324331.10
TSL:1
c.550G>Ap.Asp184Asn
missense
Exon 2 of 7ENSP00000316335.5O95363
FARS2
ENST00000897566.1
c.550G>Ap.Asp184Asn
missense
Exon 3 of 8ENSP00000567625.1

Frequencies

GnomAD3 genomes
AF:
0.000204
AC:
31
AN:
152076
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00151
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.000256
AC:
64
AN:
250094
AF XY:
0.000185
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00159
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000529
Gnomad OTH exome
AF:
0.000490
GnomAD4 exome
AF:
0.0000828
AC:
121
AN:
1460844
Hom.:
0
Cov.:
32
AF XY:
0.0000729
AC XY:
53
AN XY:
726722
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00148
AC:
66
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86252
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52402
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000414
AC:
46
AN:
1111992
Other (OTH)
AF:
0.000149
AC:
9
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
10
19
29
38
48
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000204
AC:
31
AN:
152192
Hom.:
0
Cov.:
32
AF XY:
0.000228
AC XY:
17
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41516
American (AMR)
AF:
0.00151
AC:
23
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5162
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4808
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68018
Other (OTH)
AF:
0.00142
AC:
3
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000532
Hom.:
0
Bravo
AF:
0.000431
ExAC
AF:
0.000148
AC:
18
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
Combined oxidative phosphorylation defect type 14 (2)
-
2
-
not provided (2)
-
1
-
Combined oxidative phosphorylation defect type 14;C5569007:Hereditary spastic paraplegia 77 (1)
-
1
-
Inborn genetic diseases (1)
-
1
-
See cases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Benign
-0.11
CADD
Pathogenic
30
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.50
D
Eigen
Pathogenic
0.94
Eigen_PC
Pathogenic
0.84
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Pathogenic
0.99
D
M_CAP
Uncertain
0.19
D
MetaRNN
Pathogenic
0.87
D
MetaSVM
Uncertain
0.46
D
MutationAssessor
Pathogenic
4.1
H
PhyloP100
9.4
PrimateAI
Uncertain
0.61
T
PROVEAN
Pathogenic
-4.7
D
REVEL
Pathogenic
0.69
Sift
Uncertain
0.013
D
Sift4G
Uncertain
0.018
D
Polyphen
1.0
D
Vest4
0.91
MutPred
0.85
Loss of disorder (P = 0.1335)
MVP
0.99
MPC
0.64
ClinPred
0.50
D
GERP RS
5.7
Varity_R
0.62
gMVP
0.77
Mutation Taster
=12/88
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs554931092; hg19: chr6-5369353; API